Hackernews posts about Novo Nordisk
Related:
Ozempic
- Pharma giant Novo Nordisk discloses breach of clinical trials data (www.bleepingcomputer.com)
- Data Leak at Ozempic Manufacturer Novo Nordisk (www.heise.de)
- Novo Nordisk reports cyberattack as UK gives Wegovy pill the nod (www.theregister.com)
- FulcrumSec Leaks Novo Nordisk Data After $25M Demand Goes Unpaid (databreaches.net)
- A Leaked GitHub Token Exposed the Exact Ozempic Formula (www.pentesty.co)
- Novo Nordisk's Canadian Mistake (www.science.org)
- Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war (www.theguardian.com)
- FDA approves Novo Nordisk's Wegovy pill, the first and only oral GLP-1 (www.prnewswire.com)
- Novo Nordisk slashes Wegovy price for patients lacking insurance benefits (www.washingtonpost.com)
- Novo Nordisk will lose billions because it didn't pay a couple hundred dollars (www.marketwatch.com)
- Novo Nordisk fights to keep Medicaid paying for weight-loss drugs (www.reuters.com)
- Novo Nordisk's Canadian Mistake (www.science.org)
- Novo Nordisk sells hit weight-loss drug in China–at fraction of US price (arstechnica.com)
- Novo Nordisk's Canadian Mistake (www.science.org)
- Novo Nordisk misread the US market for Wegovy, its weight loss sensation (www.reuters.com)
- EIFO and the Novo Nordisk Foundation Acquire the Most Powerful Quantum Computer (novonordiskfonden.dk)
- SAP has just become Europe's most valuable company, dethroning Novo Nordisk (www.euronews.com)
- Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says (www.reuters.com)
- Amid restructuring, Novo Nordisk directs employees to return to office (www.fiercepharma.com)
- Novo Nordisk's Growth Sputters as US Competition Dents Obesity Sales (www.bloomberg.com)
- Novo Nordisk ousts CEO after falling behind in weight loss market (www.reuters.com)
- Novo Nordisk Falls Most on Record After New Weight Drug Disappoints (www.bloomberg.com)
- Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash (www.reuters.com)
- Novo Nordisk Warns of First Sales Drop Since Start of Ozempic (www.nytimes.com)